Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

Slot R.E.R., Sikkes S.A.M., Berkhof J., Brodaty H., Buckley R., Cavedo E., Dardiotis E., Guillo-Benarous F., Hampel H., Kochan N.A., Lista S., Luck T., Maruff P., Molinuevo J.L., Kornhuber J., Reisberg B., Riedel-Heller S.G., Risacher S.L., Roehr S., Sachdev P.S., Scarmeas N., Scheltens P., Shulman M.B., Saykin A.J., Verfaillie S.C.J., Visser P.J., Vos S.J.B., Wagner M., Wolfsgruber S., Jessen F., Boada M., de Deyn P.P., Jones R., Frisoni G., Spiru L., Nobili F., Freund-Levi Y., Soininen H., Verhey F., Wallin Å.K., Touchon J., Rikkert M.O., Rigaud A.-S., Bullock R., Tsolaki M., Vellas B., Wilcock G., Froelich L., Bakardjian H., Benali H., Bertin H., Bonheur J., Boukadida L., Boukerrou N., Chiesa P., Colliot O., Dubois B., Dubois M., Epelbaum S., Gagliardi G., Genthon R., Habert M.-O., Houot M., Kas A., Lamari F., Levy M., Metzinger C., Mochel F., Nyasse F., Poisson C., Potier M.-C., Revillon M., Santos A., Andrade K.S., Sole M., Surtee M., Thiebaud de Schotten M., Vergallo A., Younsi N., van der Flier W.M., Alzheimer's Disease Neuroimaging Initiative, DESCRIPA working group, INSIGHT-preAD study group, SCD-I working group

Συγγραφέας

Slot R.E.R., Sikkes S.A.M., Berkhof J., Brodaty H., Buckley R., Cavedo E., Dardiotis E., Guillo-Benarous F., Hampel H., Kochan N.A., Lista S., Luck T., Maruff P., Molinuevo J.L., Kornhuber J., Reisberg B., Riedel-Heller S.G., Risacher S.L., Roehr S., Sachdev P.S., Scarmeas N., Scheltens P., Shulman M.B., Saykin A.J., Verfaillie S.C.J., Visser P.J., Vos S.J.B., Wagner M., Wolfsgruber S., Jessen F., Boada M., de Deyn P.P., Jones R., Frisoni G., Spiru L., Nobili F., Freund-Levi Y., Soininen H., Verhey F., Wallin Å.K., Touchon J., Rikkert M.O., Rigaud A.-S., Bullock R., Tsolaki M., Vellas B., Wilcock G., Froelich L., Bakardjian H., Benali H., Bertin H., Bonheur J., Boukadida L., Boukerrou N., Chiesa P., Colliot O., Dubois B., Dubois M., Epelbaum S., Gagliardi G., Genthon R., Habert M.-O., Houot M., Kas A., Lamari F., Levy M., Metzinger C., Mochel F., Nyasse F., Poisson C., Potier M.-C., Revillon M., Santos A., Andrade K.S., Sole M., Surtee M., Thiebaud de Schotten M., Vergallo A., Younsi N., van der Flier W.M., Alzheimer's Disease Neuroimaging Initiative, DESCRIPA working group, INSIGHT-preAD study group, SCD-I working group

Ημερομηνία

2019

Γλώσσα

DOI

10.1016/j.jalz.2018.10.003

Εμφάνιση Μεταδεδομένων

Επιτομή

Introduction: In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence of Alzheimer's disease (AD) and non-AD dementia and (2) determinants of progression to dementia. Methods: Eleven cohorts provided 2978 participants with SCD and 1391 controls. We estimated dementia incidence and identified risk factors using Cox proportional hazards models. Results: In SCD, incidence of dementia was 17.7 (95% Poisson confidence interval 15.2-20.3)/1000 person-years (AD: 11.5 [9.6-13.7], non-AD: 6.1 [4.7-7.7]), compared with 14.2 (11.3-17.6) in controls (AD: 10.1 [7.7-13.0], non-AD: 4.1 [2.6-6.0]). The risk of dementia was strongly increased in SCD in a memory clinic setting but less so in a community-based setting. In addition, higher age (hazard ratio 1.1 [95% confidence interval 1.1-1.1]), lower Mini–Mental State Examination (0.7 [0.66-0.8]), and apolipoprotein E ε4 (1.8 [1.3-2.5]) increased the risk of dementia. Discussion: SCD can precede both AD and non-AD dementia. Despite their younger age, individuals with SCD in a memory clinic setting have a higher risk of dementia than those in community-based cohorts. © 2018 The Authors

URI

http://hdl.handle.net/11615/79127

Collections

Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]